Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
1.
J Urol ; 203(6): 1219-1221, 2020 06.
Article in English | MEDLINE | ID: mdl-32068490
2.
J. trauma acute care surg ; 78(1)Jan. 2015. ilus
Article in English | BIGG - GRADE guidelines | ID: biblio-965698

ABSTRACT

BACKGROUND: Blunt traumatic aortic injury (BTAI) is the second most common cause of death in trauma patients. Eighty percent of patients with BTAI will die before reaching a trauma center. The issues of how to diagnose, treat, and manage BTAI were first addressed by the Eastern Association for the Surgery of Trauma (EAST) in the practice management guidelines on this topic published in 2000. Since that time, there have been advances in the management of BTAI. As a result, the EAST guidelines committee decided to develop updated guidelines for this topic using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework recently adopted by EAST. METHODS: A systematic review of the MEDLINE database using PubMed was performed. The search retrieved English language articles regarding BTAI from 1998 to 2013. Letters to the editor, case reports, book chapters, and review articles were excluded. Topics of investigation included imaging to diagnose BTAI, type of operative repair, and timing of operative repair. RESULTS: Sixty articles were identified. Of these, 51 articles were selected to construct the guidelines. CONCLUSION: There have been changes in practice since the publication of the previous guidelines in 2000. Computed tomography of the chest with intravenous contrast is strongly recommended to diagnose clinically significant BTAI. Endovascular repair is strongly recommended for patients without contraindications. Delayed repair of BTAI is suggested, with the stipulation that effective blood pressure control must be used in these patients.(AU)


Subject(s)
Humans , Tomography, X-Ray Computed , Vascular System Injuries/diagnostic imaging , Endovascular Procedures
4.
Urologe A ; 52(8): 1080-3, 2013 Aug.
Article in German | MEDLINE | ID: mdl-23712423

ABSTRACT

Randomized controlled trials (RCTs) stopped prematurely for beneficial therapy effects are becoming increasingly more prevalent in the urological literature and often receive great attention in the public and medical media. Urologists who practice evidence-based medicine should be aware of the potential bias and the different reasons why and how early termination of RCTs can and will affect the results. This review provides insights into the challenges clinical urologists face by interpreting the results of prematurely terminated RCTs.


Subject(s)
Bias , Evidence-Based Medicine , Outcome Assessment, Health Care/methods , Outcome Assessment, Health Care/statistics & numerical data , Physicians/statistics & numerical data , Randomized Controlled Trials as Topic/methods , Randomized Controlled Trials as Topic/statistics & numerical data , Humans
5.
Urologe A ; 52(7): 982-5, 2013 Jul.
Article in German | MEDLINE | ID: mdl-23708004

ABSTRACT

Likelihood ratios (LRs) can be used to assess in an efficient manner the change of a pre-test probability to the post-test probability of a disease based on a given test result. For any clinical question or condition of interest, the diagnostic benefit can be calculated for each diagnostic test allowing to compare the performance of different diagnostic tests. Urologists should become familiar with the use of LR to promote a more evidence-based application of diagnostic test for different clinical scenarios. This review provides insights in the calculation and use of LR.


Subject(s)
Data Interpretation, Statistical , Decision Support Techniques , Diagnostic Techniques, Urological , Evidence-Based Medicine , Likelihood Functions , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/therapy , Humans
6.
Urologe A ; 52(6): 838-41, 2013 Jun.
Article in German | MEDLINE | ID: mdl-23703691

ABSTRACT

Kaplan-Meier curves and estimates of survival are the most common way to present survival data in medicine, especially for cohorts with different lengths of follow-up. Moreover, Kaplan-Meier curves present a frequently used general graphic approach to display time-to-event outcomes. A solid understanding of how Kaplan-Meier curves are generated and how they should be analyzed and interpreted is of great importance to appraise urological literature in daily clinical practice. This article describes the basic principles of Kaplan-Meier analysis, possible variants and pitfalls. Improved knowledge of Kaplan-Meier analysis can help to improve Evidence-based urology and its application in patient care.


Subject(s)
Geriatric Assessment/methods , Geriatric Assessment/statistics & numerical data , Kaplan-Meier Estimate , Risk Assessment/methods , Risk Assessment/statistics & numerical data , Urologic Neoplasms/mortality , Urology/methods , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prognosis
7.
Urologe A ; 52(5): 682-5, 2013 May.
Article in German | MEDLINE | ID: mdl-23532201

ABSTRACT

The number needed to treat (NNT) is a useful way for clinicans to describe the benefit or harm of a treatment as well as the costs involved. When interpreting the NNT it is essential to use the NNT in a clinically equivalent and appropriate setting. When evaluating the consequences of a treatment clinicians should make sure that the patients being treated have the same risk profile asthe study patients. Differences in duration of follow-up and baseline risks can cause significant changes in the NNT; therefore, NNT should be evaluated in addition to relative risk differences and baseline risk to reduce any ambivalence in the assessment of a treatment. This review provides insights into the assessment and clinical use of NNT in the practice.


Subject(s)
Data Interpretation, Statistical , Numbers Needed To Treat/statistics & numerical data , Outcome Assessment, Health Care/methods , Risk Reduction Behavior , Urologic Diseases/epidemiology , Urologic Diseases/therapy , Urology/statistics & numerical data , Germany/epidemiology , Humans , Prevalence
9.
Urologe A ; 52(3): 367-72, 2013 Mar.
Article in German | MEDLINE | ID: mdl-23503794

ABSTRACT

Applying evidence-based medicine in daily clinical practice is the basis of patient-centered medicine and knowledge of accurate literature acquisition skills is necessary for informed clinical decision-making. PubMed is an easy accessible, free bibliographic database comprising over 21 million citations from the medical field, life-science journals and online books. The article summarizes the effective use of PubMed in routine urological clinical practice based on a common case scenario. This article explains the simple use of PubMed to obtain the best search results with the highest evidence. Accurate knowledge about the use of PubMed in routine clinical practice can improve evidence-based medicine and also patient treatment.


Subject(s)
Data Mining/methods , Evidence-Based Medicine/methods , Practice Patterns, Physicians'/organization & administration , PubMed , Urology/methods , Germany
10.
Urologe A ; 52(4): 546-8, 2013 Apr.
Article in German | MEDLINE | ID: mdl-23511856

ABSTRACT

Confidence intervals and p-values are widely used in the urological literature to describe and interpret outcomes. However, several readers, authors and reviewers are unfamiliar with the true interpretation of these values. P-values determine statistical significance of data. Confidence intervals characterize a range of values in which the true effect size is suggested to be with a given degree of certainty. An independent but complementary interpretation of both values is important in studies with and without statistical significance. Based on a clinical case scenario this article discusses the interpretation as well as common pitfalls in interpretation of p-values and confidence intervals. An accurate assessment of these statistical cornerstones is fundamental for a correct interpretation of the urological literature and thus important aspects of evidence-based urology.


Subject(s)
Data Interpretation, Statistical , Evidence-Based Medicine/statistics & numerical data , Outcome Assessment, Health Care/methods , Urologic Diseases/epidemiology , Urologic Diseases/therapy , Confidence Intervals , Humans , Treatment Outcome
11.
Acta Anaesthesiol Scand ; 53(7): 908-13, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19456301

ABSTRACT

BACKGROUND: Severe pain in the head and neck is associated with a lowered quality of life and conventional pain therapy often does not provide adequate relief. The aims of this study were to investigate the efficacy, pain relief, benefits and adverse effects of intracisternal or high cervical (IHC) administration of bupivacaine in patients with severe pain in the head, neck and face regions. METHODS: Between 1990 and 2005, 40 patients (age 27-84 years) were treated with continuous IHC infusions of bupivacaine for various non-cancer (n=15) or cancer-related (n=25) refractory pain conditions (duration 1 month-18 years) in the head, neck, mouth and shoulder regions. RESULTS: Visual analogue scale scores and opioid requirements decreased markedly after the start of the treatment and remained lowered throughout the study. No tachyphylaxis for bupivacaine was observed. Major side effects were few and most often transient. Most patients showed unchanged or improved mobility. There was no mortality, neurological damage or other severe events attributable to procedures in the study protocol. CONCLUSION: For patients with severe and refractory pain in areas innervated by cranial and upper cervical nerves, cervical high spinal analgesia can provide safe and effective analgesia.


Subject(s)
Anesthetics, Local/administration & dosage , Anesthetics, Local/therapeutic use , Bupivacaine/administration & dosage , Bupivacaine/therapeutic use , Headache/drug therapy , Neck Pain/drug therapy , Adult , Aged , Aged, 80 and over , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/therapeutic use , Anesthetics, Local/adverse effects , Bupivacaine/adverse effects , Female , Follow-Up Studies , Humans , Injections, Spinal , Male , Middle Aged , Pain Measurement , Sleep/drug effects , Walking
12.
Prostate Cancer Prostatic Dis ; 10(1): 72-6, 2007.
Article in English | MEDLINE | ID: mdl-17179978

ABSTRACT

The aim of the study was to prospectively assess the role of apical soft tissue biopsies in radical perineal prostatectomy (RPP) patients with documented apical prostate cancer (PCA) involvement. Between June 1998 and May 1999, 77 consecutive men with localized PCA and documented invasion of the prostatic apex underwent RPP by a single surgeon. Soft tissue biopsies were systematically obtained from the prostatic fossa overlying the apex at the time of surgery. Time to biochemical failure was calculated using the Kaplan-Meier method. The rates of positive apical margins and positive apical soft tissue biopsies were 23.4% (18/77) and 15.6% (12/77). The sensitivity, specificity and positive predictive value of positive apical margins for residual apical disease as determined by apical soft tissue biopsy were 41.7, 80, and 28%, respectively. The overall biochemical failure rate was 28.6% (22/77) with a median follow-up of 51 months (range 3-73 months). The 36-month biochemical recurrence-free survival rate was 55.9+/-14.9% for patients with positive apical biopsies and 78.7+/-5.3% for those with negative biopsies (P=0.023). In conclusion, positive apical soft tissue biopsy is an independent predictor of biochemical failure in patients with apical PCA who undergo RPP. Positive apical surgical margins poorly predict residual apical disease that is frequently identifiable by apical soft tissue biopsy. Apical soft tissue biopsies should therefore be obtained in patients with known extensive apical cancer involvement at the time of RPP.


Subject(s)
Biopsy/methods , Carcinoma/diagnosis , Carcinoma/pathology , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/pathology , Adult , Aged , Carcinoma/surgery , Diagnostic Techniques, Surgical , Humans , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm, Residual/diagnosis , Neoplasm, Residual/pathology , Perineum/pathology , Perineum/surgery , Prognosis , Prostatectomy/methods , Prostatic Neoplasms/surgery , Treatment Failure
13.
Prostate Cancer Prostatic Dis ; 9(3): 254-60, 2006.
Article in English | MEDLINE | ID: mdl-16880828

ABSTRACT

To determine the timing and patterns of late recurrence after radical prostatectomy (RP) alone or RP plus adjuvant radiotherapy (RT). Between 1970 and 1983, 159 patients underwent RP for newly diagnosed adenocarcinoma of the prostate and were found to have positive surgical margins, extracapsular extension and/or seminal vesicle invasion. Of these, 46 received adjuvant RT and 113 did not. The RT group generally received 45-50 Gy to the whole pelvis, then a boost to the prostate bed (total dose of 55-65 Gy). In the RP group, 62% received neoadjuvant/adjuvant androgen deprivation vs 17% in the RT group. Patients were analyzed with respect to timing and patterns of failure. Only one patient was lost to follow-up. The median follow-up for surviving patients was nearly 20 years. The median time to failure in the surgery group was 7.5 vs 14.7 years in the RT group (P=0.1). Late recurrences were less common in the surgery group than the RT group (9 and 1% at 10 and 15 years, respectively vs 17 and 9%). In contrast to recurrences, nearly half of deaths from prostate cancer occurred more than 10 years after treatment. Deaths from prostate cancer represented 55% of all deaths in these patients. Recurrences beyond 10 years after RP in this group of patients were relatively uncommon. Despite its long natural history, death from prostate cancer was the most common cause of mortality in this population with locally advanced tumors, reflecting the need for more effective therapy.


Subject(s)
Adenocarcinoma/pathology , Adenocarcinoma/radiotherapy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/radiotherapy , Adenocarcinoma/mortality , Adult , Aged , Antineoplastic Agents, Hormonal/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Disease-Free Survival , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/radiotherapy , Neoplasm Staging , Pelvis/radiation effects , Prostatectomy/methods , Prostatic Neoplasms/mortality , Radiation Dosage , Radiotherapy, Adjuvant , Retrospective Studies , Survival Analysis , Time Factors , Treatment Failure
14.
Prostate Cancer Prostatic Dis ; 8(3): 293-5; discussion 295, 2005.
Article in English | MEDLINE | ID: mdl-15897914

ABSTRACT

Prostate cancer often metastasizes to the regional lymph nodes, but metastases to distant supradiaphragmatic lymph nodes are uncommon. Rare case reports describe cervical lymph node metastases as the first clinical manifestation of prostate cancer, but only in the setting of widely disseminated disease. We present the unusual case of an 84-y-old male with a known history of prostate cancer and recurrent disease limited to the left supraclavicular lymph nodes.


Subject(s)
Head and Neck Neoplasms/diagnosis , Lymphatic Metastasis , Neoplasm Metastasis , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/pathology , Aged , Humans , Male , Prostate-Specific Antigen/biosynthesis , Recurrence , Time Factors , Tomography, X-Ray Computed
15.
Cytopathology ; 14(5): 249-56, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14510888

ABSTRACT

The atypical squamous cells of undetermined significance (ASCUS) : squamous intraepithelial lesion (SIL) ratio was proposed to monitor laboratory use of the ASCUS diagnosis. This study addresses problems associated with comparing pathologists by this means. An intuitive example showed the ASCUS : SIL ratio depends on the prevalence of smears from patients who actually have SIL. In this study of 2000 cervical smears, each of five pathologists made 400 diagnoses. Differences among proportions of SIL diagnoses were statistically significant; differences among proportions of ASCUS diagnoses were not. Had an ASCUS : SIL ratio upper limit of 3.0 been used, two pathologists would have been misidentified as having high ASCUS diagnosis rates. Unlike the situation for laboratories, potential variability in SIL prevalence requires caution in the use of this ratio in assessing pathologists. An alternative measure that is independent of prevalence, the ASCUS : SIL odds ratio, is posited.


Subject(s)
Pathology/standards , Precancerous Conditions/diagnosis , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Neoplasms/diagnosis , Vaginal Smears , Diagnosis, Differential , Female , Humans , Laboratories/standards , Observer Variation , Pathology/methods , Precancerous Conditions/classification , Quality Control , Reference Standards , Uterine Cervical Neoplasms/classification , Vaginal Smears/methods , Vaginal Smears/standards , Vaginal Smears/statistics & numerical data , Uterine Cervical Dysplasia/classification
16.
Urologe A ; 42(7): 933-9, 2003 Jul.
Article in German | MEDLINE | ID: mdl-12898037

ABSTRACT

We report on a large series of 1,275 patients who underwent outpatient vasectomy performed by a single urological surgeon within a 10-year period. In addition, the results of a prospective questionnaire-based study on 217 patients regarding their opinions and motivation, and the financial aspects of the vasectomy are discussed. The mean age was 37.0+/-5.9 years. A total of 98.4% of the patients had an uneventful postoperative course. The average duration of sick leave was 2.2+/-0.21 days. During the study period, the length of sick leave dropped significantly from 2.63 (1990/91) to 1.1 days (1998/99; P=0.001). Efficacy was documented with azoospermia rates of 96.6% and 98.5% in patients who presented for two and three sperm examinations, respectively. A vast majority of patients (94.6%) felt that the procedure should be covered by their health insurance, although 88.1% stated they would also pay by themselves. A minority of patients (0.7%: 9/1,275) subsequently considered vasectomy reversal. The wish to reverse the vasectomy was significantly associated with a younger patient age. In conclusion, outpatient vasectomy provides a safe and reliable form of contraception at low cost. Overall satisfaction in appropriately counselled patients is very high. Based on these findings, further attempts to propagate vasectomy as a timely form of contraception are medically and socioeconomically recommended.


Subject(s)
Minimally Invasive Surgical Procedures , Postoperative Complications/epidemiology , Vasectomy/statistics & numerical data , Adolescent , Adult , Aged , Ambulatory Surgical Procedures , Follow-Up Studies , Germany , Humans , Male , Middle Aged , Patient Satisfaction/statistics & numerical data , Postoperative Complications/surgery , Reoperation/statistics & numerical data , Sick Leave/statistics & numerical data , Sperm Count , Surveys and Questionnaires , Vasovasostomy/statistics & numerical data
17.
Biometrics ; 58(4): 1028-31; discussion 1032-3, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12495159

ABSTRACT

Böhm et al. (1995, Human Genetics 95, 249-256) introduced a statistical model (named FSM--fragile site model) specifically designed for the identification of fragile sites from chromosomal breakage data. In response to claims to the contrary (Hou et al., 1999, Human Genetics 104, 350-355; Hou et al., 2001, Biometrics 57, 435-440), we show how the FSM model is correctly modified for application under the assumption that the probability of random breakage is proportional to chromosomal band length and how the purportedly alternative procedures proposed by Hou, Chang, and Tai (1999, 2001) are variations of the correctly modified FSM algorithm. With the exception of the test statistic employed, the procedure described by Hou et al. (1999) is shown to be functionally identical to the correctly modified FSM and the application of an incorrectly modified FSM is shown to invalidate all of the comparisons of FSM to the alternatives proposed by Hou et al. (1999, 2001). Last, we discuss the statistical implications of the methodological variations proposed by Hou et al. (2001) and emphasize the logical and statistical necessity for fragile site identifications to be based on data from single individuals.


Subject(s)
Chromosome Fragility , Models, Genetic , Models, Statistical , Algorithms , Chromosome Fragile Sites , Data Interpretation, Statistical , Humans
18.
J Endourol ; 15(8): 835-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11724125

ABSTRACT

PURPOSE: We review our technique of ureteroscopic management of lower pole renal calculi with Nitinol basket displacement and holmium laser stone fragmentation. METHODS: Lower pole calculi are identified with a 7.5F flexible ureteroscope. In patients in whom the laser fiber reduces ureteroscopic deflection, precluding reentry into the lower pole, a Nitinol basket or grasper is used to displace the calculi into an upper pole calix for easier fragmentation. RESULTS: The Nitinol device can be passed into the lower pole through the fully deflected ureteroscope without any loss of deflection. Irrigation is significantly reduced by the basket, but this factor does not impede stone retrieval. CONCLUSIONS: Ureteroscopic management of lower pole stones is a reasonable alternative to SWL or percutaneous nephrolithotomy in low-volume stone disease. If the stone cannot be fragmented in situ, Nitinol basket capture through a fully deflected ureteroscope into a less dependent position facilitates stone fragmentation.


Subject(s)
Kidney Calculi/surgery , Ureteroscopy/methods , Equipment Design , Humans , Laser Therapy , Stents , Urology/instrumentation , Urology/methods
19.
Anesthesiology ; 95(5): 1079-82, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11684974

ABSTRACT

BACKGROUND: It is generally argued that variations in cerebral blood flow create concomitant changes in the cerebral blood volume (CBV). Because nitrous oxide (N(2)O) inhalation both increases cerebral blood flow and may increase intracranial pressure, it is reasonable to assume that N(2)O acts as a general vasodilatator in cerebral vessels both on the arterial and on the venous side. The aim of the current study was to evaluate the effect of N(2)O on three-dimensional regional and global CBV in humans during normocapnia and hypocapnia. METHODS: Nine volunteers were studied under each of four conditions: normocapnia, hypocapnia, normocapnia + 40-50% N(2)O, and hypocapnia + 40-50% N(2)O. CBV was measured after (99m)Tc-labeling of blood with radioactive quantitative registration via single photon emission computer-aided tomography scanning. RESULTS: Global CBV during normocapnia and inhalation of 50% O(2) was 4.25 +/- 0.57% of the brain volume (4.17 +/- 0.56 ml/100 g, mean +/- SD) with no change during inhalation of 40-50% N(2)O in O(2). Decreasing carbon dioxide (CO(2)) by 1.5 kPa (11 mmHg) without N(2)O inhalation and by 1.4 kPa (11 mmHg) with N(2)O inhalation reduced CBV significantly (F = 57, P < 0.0001), by 0.27 +/- 0.10% of the brain volume per kilopascal (0.26 +/- 0.10 ml x 100 g(-1) x kPa(-1)) without N(2)O inhalation and by 0.35 +/- 0.22% of the brain volume per kilopascal (0.34 +/- 0.22 ml x 100 g(-1) x kPa(-1)) during N(2)O inhalation (no significant difference). The amount of carbon dioxide significantly altered the regional distribution of CBV (F = 47, P < 0.0001), corresponding to a regional difference in Delta CBV when CO(2) is changed. N(2)O inhalation did not significantly change the distribution of regional CBV (F = 2.4, P = 0.051) or Delta CBV/Delta CO(2) in these nine subjects. CONCLUSIONS: Nitrous oxide inhalation had no effect either on CBV or on the normal CBV-CO(2) response in humans.


Subject(s)
Anesthetics, Inhalation/pharmacology , Blood Volume/drug effects , Brain/drug effects , Hypocapnia/metabolism , Nitrous Oxide/pharmacology , Adult , Brain/diagnostic imaging , Carbon Dioxide/pharmacology , Dose-Response Relationship, Drug , Hemodynamics/drug effects , Humans , Male , Tomography, Emission-Computed, Single-Photon
SELECTION OF CITATIONS
SEARCH DETAIL
...